HEPATITIS E VIRUS (HEV) ANTIBODY - IGM

The Hepatitis E Virus (HEV) IgM Antibody Test is a laboratory blood test that detects Immunoglobulin M (IgM) antibodies against the Hepatitis E Virus (HEV). It is the preferred serological test for diagnosing recent or acute hepatitis E infection, helping healthcare providers identify the infection during its early stages.

Hepatitis E is a viral liver infection caused by the Hepatitis E Virus. It is primarily transmitted through the fecal-oral route, most commonly by consuming contaminated drinking water or food. In some countries, certain HEV genotypes may also spread through undercooked pork, deer meat, or organ transplantation. Outbreaks are more common in regions with poor sanitation and inadequate access to clean water.

Most HEV infections are self-limiting, and affected individuals recover completely within a few weeks. However, hepatitis E can be severe in pregnant women, particularly during the third trimester, where it may lead to acute liver failure and increased maternal and fetal complications. Individuals with weakened immune systems or chronic liver disease may also experience more serious illness.

Symptoms of acute hepatitis E typically include fever, fatigue, nausea, vomiting, abdominal pain, loss of appetite, dark urine, pale stools, jaundice (yellowing of the skin and eyes), and elevated liver enzymes. Some infected individuals may have mild symptoms or remain asymptomatic.

During the early phase of infection, the immune system produces HEV IgM antibodies, which usually become detectable shortly before or around the onset of symptoms and remain positive for several weeks to a few months. Therefore, a positive HEV IgM result strongly suggests recent or current hepatitis E infection.

Doctors often request the HEV IgM Antibody Test when evaluating patients with acute hepatitis symptoms, unexplained jaundice, abnormal liver function tests, recent travel to endemic regions, or suspected waterborne hepatitis outbreaks. In selected cases, particularly in immunocompromised individuals, HEV RNA molecular testing may also be recommended to confirm active infection.

Benefits of the Test

• Detects recent or acute Hepatitis E infection.
• Supports early diagnosis of viral hepatitis.
• Helps identify the immune response during active infection.
• Assists in evaluating unexplained jaundice.
• Useful during hepatitis outbreaks.
• Requires only a simple blood sample.
• Reliable laboratory immunoassay.
• Supports timely medical management.

Why Doctors Recommend This Test

Doctors recommend the HEV IgM Antibody Test for patients with symptoms of acute hepatitis, jaundice, abnormal liver function tests, recent travel to endemic areas, suspected contaminated water exposure, or during community outbreaks of hepatitis E.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise by your healthcare provider. Inform your doctor about recent travel, pregnancy, liver disease, medications, or possible exposure to contaminated food or water. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 2–5 Working Days

Reporting time may vary depending on laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Individuals with symptoms of acute hepatitis.
• Patients with jaundice.
• People with abnormal liver function tests.
• Travelers returning from HEV-endemic regions.
• Individuals exposed to contaminated water or food.
• Pregnant women with suspected hepatitis (under medical supervision).
• Patients involved in hepatitis outbreaks.
• Individuals referred by hepatologists or infectious disease specialists.
• Immunocompromised patients when clinically indicated.
• Anyone advised by their healthcare provider.